Literature DB >> 30640680

Correlation between the diversity of vaginal microbiota and the risk of high-risk human papillomavirus infection.

Xiao-Pei Chao1, Ting-Ting Sun1, Shu Wang2, Qing-Bo Fan2, Hong-Hui Shi1, Lan Zhu2, Jing-He Lang1.   

Abstract

OBJECTIVES: Since other genital infections enhance HIV susceptibility by inducing inflammation and evidence suggests that the vaginal microbiome plays a functional role in the persistence or regression of high-risk human papillomavirus (HPV) infections, we investigated the relationship between the composition of the vaginal microbiota and the risk of high-risk HPV infection.
METHODS: The study included 151 healthy women (65 HPV-positive and 86 HPV-negative) aged 20-65 at enrollment. Total genome DNA from samples was extracted using the hexadecyltrimethylammonium bromide (CTAB) CTAB method. The vaginal microbiota composition was determined by sequencing barcoded 16S rDNA gene fragments (V4) on Illumina HiSeq2500.
RESULTS: Of the 30 most abundant bacteria at the genus level, we found only six bacteria with a statistical difference between HPV-positive and HPV-negative women: Bacteroides, Acinetobacter, Faecalibacterium, Streptococcus, Finegoldia, and Moryella. Lactobacillus was the predominant genus and was detected in all women, but there was no significant difference between the two groups for L. iners, L. jensenii, and L. gasseri. Furthermore, we found 26 types of bacteria with a statistical difference at the species level between the two groups. Anaerobic bacteria such as Bacteroides plebeius, Acinetobacter lwoffii, and Prevotella buccae were found significantly more frequently in HPV-positive women, which is the most important finding of our study.
CONCLUSION: Our findings suggest a possible role for the composition of the vaginal microbiota as a modifier of high-risk HPV infection, and specific microbiota species may serve as sensors for changes in the cervical microenvironment associated with high-risk HPV infection. The exact molecular mechanism of the vaginal microbiota in the course of high-risk HPV infection and cervical neoplasia should be further explored. Future research should include intervention in the composition of the vaginal microbiota to reverse the course of high-risk HPV infection and the natural history of cervical neoplasia. © IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  16S rRNA; human papillomavirus (HPV); span> rRNA; vaginal microbiota composition

Year:  2019        PMID: 30640680     DOI: 10.1136/ijgc-2018-000032

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  23 in total

1.  The Diversity of Vaginal Microbiota Predicts Neoadjuvant Chemotherapy Responsiveness in Locally Advanced Cervical Cancer.

Authors:  Zizhuo Wang; Rourou Xiao; Jia Huang; Xu Qin; Dianxing Hu; Ensong Guo; Chen Liu; Funian Lu; Lixin You; Chaoyang Sun; Gang Chen
Journal:  Microb Ecol       Date:  2021-08-17       Impact factor: 4.552

2.  Effects of Vine Tea Extract on Meat Quality, Gut Microbiota and Metabolome of Wenchang Broiler.

Authors:  Luli Zhou; Hui Li; Guanyu Hou; Jian Wang; Hanlin Zhou; Dingfa Wang
Journal:  Animals (Basel)       Date:  2022-06-28       Impact factor: 3.231

3.  Prevalence of HPV and associated factors in a population of women living in southern Brazil.

Authors:  Ana Paula Reolon Bortolli; Indianara Carlotto Treco; Valquíria Kulig Vieira; Claudicéia Risso Pascotto; Lirane Elize Defante Ferreto; Guilherme Welter Wendt; Léia Carolina Lucio
Journal:  Braz J Microbiol       Date:  2022-10-20       Impact factor: 2.214

Review 4.  Vaginal microbiomes and ovarian cancer: a review.

Authors:  Jinyun Xu; Jing-Jie Peng; Wenqing Yang; Kun Fu; Yu Zhang
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

5.  Entamoeba gingivalis: epidemiology, genetic diversity and association with oral microbiota signatures in North Eastern Tanzania.

Authors:  Christen Rune Stensvold; Michelle Nielsen; Vito Baraka; Rolf Lood; Kurt Fuursted; Henrik Vedel Nielsen
Journal:  J Oral Microbiol       Date:  2021-05-19       Impact factor: 5.474

6.  The cervical microbiota in reproductive-age South African women with and without human papillomavirus infection.

Authors:  Harris Onywera; Anna-Lise Williamson; Zizipho Z A Mbulawa; David Coetzee; Tracy L Meiring
Journal:  Papillomavirus Res       Date:  2019-04-13

Review 7.  Understanding genomics and the immune environment of penile cancer to improve therapy.

Authors:  Ahmet Murat Aydin; Jad Chahoud; Jacob J Adashek; Mounsif Azizi; Anthony Magliocco; Jeffrey S Ross; Andrea Necchi; Philippe E Spiess
Journal:  Nat Rev Urol       Date:  2020-08-18       Impact factor: 14.432

Review 8.  The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities.

Authors:  Laura M Chambers; Parker Bussies; Roberto Vargas; Emily Esakov; Surabhi Tewari; Ofer Reizes; Chad Michener
Journal:  Curr Oncol Rep       Date:  2021-06-14       Impact factor: 5.075

Review 9.  A Framework for Cervical Cancer Elimination in Low-and-Middle-Income Countries: A Scoping Review and Roadmap for Interventions and Research Priorities.

Authors:  Michelle B Shin; Gui Liu; Nelly Mugo; Patricia J Garcia; Darcy W Rao; Cara J Bayer; Linda O Eckert; Leeya F Pinder; Judith N Wasserheit; Ruanne V Barnabas
Journal:  Front Public Health       Date:  2021-07-01

Review 10.  The interplay between the vaginal microbiome and innate immunity in the focus of predictive, preventive, and personalized medical approach to combat HPV-induced cervical cancer.

Authors:  Erik Kudela; Alena Liskova; Marek Samec; Lenka Koklesova; Veronika Holubekova; Tomas Rokos; Erik Kozubik; Terezia Pribulova; Kevin Zhai; Dietrich Busselberg; Peter Kubatka; Kamil Biringer
Journal:  EPMA J       Date:  2021-05-18       Impact factor: 8.836

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.